[1] WANG Y,SHAO T,WANG J,et al.An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage[J].Biomed Pharmacother,2021,133:110991.
[2] RAFEHI H,EL-OSTA A,KARAGIANNIS T C.Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers[J].J Diabetes Complications,2012,26(6):554-561.
[3] BANDYK D F.The diabetic foot:pathophysiology,evaluation,and treatment[J].Semin Vasc Surg,2019,31(2):43-48.
[4] DEKKER A D,DAVIS F M,KUNKEL S L,et al.Targeting epigenetic mechanisms in diabetic wound healing[J].Transl Res,2019,204:39-50.
[5] DAVIS F M,KIMBALL A,BONIAKOWSKI A,et al.Dysfunctional wound healing in diabetic foot ulcers:new crossroads[J].Curr Diab Rep,2018,18(1):1-8.
[6] POP-BUSUI R,BOULTON A J,FELDMAN E L,et al.Diabetic neuropathy:a position statement by the American diabetes association[J].Diabetes Care,2017,40(1):136-154.
[7] GURTNER G C,WERNER S,BARRANDON Y,et al.Wound repair and regeneration[J].Nature,2008,453(7193):314-321.
[8] JHAMB S,VANGAVETI V N,MALABU U H.Genetic and molecular basis of diabetic foot ulcers:clinical review[J].J Tissue Viability,2016,25(4):229-236.
[9] RAFEHI H,EL OSTA A,KARAGIANNIS T C.Genetic and epigenetic events in diabetic wound healing[J].Int Wound J,2011,8(1):12-21.
[10] GIACCO F,BROWNLEE M.Oxidative stress and diabetic complications[J].Circ Res,2010,107(9):1058-1070.
[11] LIN C J,LAN Y M,OU M Q,et al.Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats[J].J Endocrinol Invest,2019,42(11):1307-1317.
[12] VISWANATHAN V.Role of molecular genetics in diabetic foot ulcer[J].Pol Arch Intern Med,2017,127(5):310-311.
[13] MIRZA R E,FANG M M,NOVAK M L,et al.Macrophage PPARgamma and impaired wound healing in type 2 diabetes[J].J Pathol,2015,236(4):433-444.
[14] GUO Y,LIN C,XU P,et al.AGEs induced autophagy impairs cutaneous wound healing via stimulating macrophage polarization to M1 in diabetes[J].Sci Rep,2016,6:36416.
[15] BONAVENTURA A,VECCHIE A,ABBATE A,et al.Neutrophil extracellular traps and cardiovascular diseases:an update[J].Cells,2020,9(1):231.
[16] SINGH K,AGRAWAL N K,GUPTA S K,et al.Genetic and epigenetic alterations in Toll like receptor 2 and wound healing impairment in type 2 diabetes patients[J].J Diabetes Complications,2015,29(2):222-229.
[17] SINGH K,AGRAWAL N K,GUPTA S K,et al.Differential expression of matrix metalloproteinase-9 gene in wounds of type 2 diabetes mellitus cases with susceptible-1562C>T genotypes and wound severity[J].Int J Low Extrem Wounds,2014,13(2):94-102.
[18] WIDGEROW A D.Chronic wound fluid-thinking outside the box[J].Wound Repair Regen,2011,19(3):287-291.
[19] BEREZIN A.Metabolic memory phenomenon in diabetes mellitus:achieving and perspectives[J].Diabetes Metab Syndr,2016,10(2 Suppl 1):S176-S183.
[20] REDDY M A,ZHANG E,NATARAJAN R.Epigenetic mechanisms in diabetic complications and metabolic memory[J].Diabetologia,2015,58(3):443-455.
[21] LIU Y F,DING M,LIU D W,et al.MicroRNA profiling in cutaneous wounds of diabetic rats[J].Genet Mol Res,2015,14(3):9614-9625.
[22] ESLAM M,VALENTI L,ROMEO S.Genetics and epigenetics of NAFLD and NASH:clinical impact[J].J Hepatol,2018,68(2):268-279.
[23] GJORGJIEVA M,SOBOLEWSKI C,DOLICKA D,et al.miRNAs and NAFLD:from pathophysiology to therapy[J].Gut,2019,68(11):2065-2079.
[24] KANTHARIDIS P,WANG B,CAREW R M,et al.Diabetes complications:the microRNA perspective[J].Diabetes,2011,60(7):1832-1837.
[25] LIU J,XU Y,SHU B,et al.Quantification of the differential expression levels of microRNA-203 in different degrees of diabetic foot[J].Int J Clin Exp Pathol,2015,8(10):13416-13420.
[26] GAREEV I,BEYLERLI O,YANG G,et al.The current state of MiRNAs as biomarkers and therapeutic tools[J].Clin Exp Med,2020,20(3):349-359.
[27] TILI E,MICHAILLE J J,CIMINO A,et al.Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock[J].J Immunol,2007,179(8):5082-5089.
[28] BHAUMIK D,SCOTT G K,SCHOKRPUR S,et al.MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8[J].Aging (Albany NY),2009,1(4):402-411.
[29] WANG J M,TAO J,CHEN D D,et al.MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus[J].Arterioscler Thromb Vasc Biol,2014,34(1):99-109.
[30] MADHYASTHA R,MADHYASTHA H,NAKAJIMA Y,et al.MicroRNA signature in diabetic wound healing:promotive role of miR-21 in fibroblast migration[J].Int Wound J,2012,9(4):355-361.
[31] POLISENO L,TUCCOLI A,MARIANI L,et al.MicroRNAs modulate the angiogenic properties of HUVECs[J].Blood,2006,108(9):3068-3071.
[32] BISWAS S,ROY S,BANERJEE J,et al.Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds[J].Proc Natl Acad Sci USA,2010,107(15):6976-6981.
[33] CAPORALI A,MELONI M,VOLLENKLE C,et al.Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia[J].Circulation,2011,123(3):282-291.
[34] ZHANG J,SUN X J,CHEN J,et al.Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy[J].J Diabetes Complications,2017,31(1):241-244.
[35] ICLI B,NABZDYK C S,LUJAN-HERNANDEZ J,et al.Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a[J].J Mol Cell Cardiol,2016,91:151-159.
[36] AMIN K N,UMAPATHY D,ANANDHARAJ A,et al.miR-23c regulates wound healing by targeting stromal cell-derived factor-1α(SDF-1α/CXCL12) among patients with diabetic foot ulcer[J].Microvasc Res,2020,127:103924.
[37] GAO J,ZHAO G,LI W,et al.MiR-155 targets PTCH1 to mediate endothelial progenitor cell dysfunction caused by high glucose[J].Exp Cell Res,2018,366(1):55-62.
[38] CARSON W T,CAVASSANI K A,SOARES E M,et al.The STAT4/MLL1 epigenetic axis regulates the antimicrobial functions of murine macrophages[J].J Immunol,2017,199(5):1865-1874.
[39] ZIMMERMANN M,AGUILERA F B,CASTELLUCCI M,et al.Chromatin remodelling and autocrine TNFalpha are required for optimal interleukin-6 expression in activated human neutrophils[J].Nat Commun,2015,6:6061.
[40] WANG X,CAO Q,YU L,et al.Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity[J].JCI Insight,2016,1(19):e87748.
[41] ZHANG J,YANG C,WANG C,et al.AGE-induced keratinocyte MMP-9 expression is linked to TET2-mediated CpG demethylation[J].Wound Repair Regen,2016,24(3):489-500.
[42] ZHOU L,WANG W,YANG C,et al.GADD45a promotes active DNA demethylation of the MMP-9 promoter via base excision repair pathway in AGEs-treated keratinocytes and in diabetic male rat skin[J].Endocrinology,2018,159(2):1172-1186.
[43] LUDWIG-SLOMCZYNSKA A H,BORYS S,SEWERYN M T,et al.DNA methylation analysis of negative pressure therapy effect in diabetic foot ulcers[J].Endocr Connect,2019,8(11):1474-1482.
[44] HAFEZ Y M,EL-DEEB O S,ATEF M M.The emerging role of the epigenetic enzyme Sirtuin-1 and high mobility group Box 1 in patients with diabetic foot ulceration[J].Diabetes Metab Syndr,2018,12(6):1065-1070.
[45] SHU Y,PI F,SHARMA A,et al.Stable RNA nanoparticles as potential new generation drugs for cancer therapy[J].Adv Drug Deliv Rev,2014,66:74-89.
[46] LOPES L,SETIA O,AURSHINA A,et al.Stem cell therapy for diabetic foot ulcers:a review of preclinical and clinical research[J].Stem Cell Res Ther,2018,9(1):188. |
